Sender v. Mann

225 F.R.D. 645, 60 Fed. R. Serv. 3d 958, 2004 U.S. Dist. LEXIS 26684, 2004 WL 3127978
CourtDistrict Court, D. Colorado
DecidedDecember 14, 2004
DocketCiv.A. No. 01-B-2315CBS
StatusPublished
Cited by54 cases

This text of 225 F.R.D. 645 (Sender v. Mann) is published on Counsel Stack Legal Research, covering District Court, D. Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sender v. Mann, 225 F.R.D. 645, 60 Fed. R. Serv. 3d 958, 2004 U.S. Dist. LEXIS 26684, 2004 WL 3127978 (D. Colo. 2004).

Opinion

MEMORANDUM ORDER REGARDING DEFENDANTS’ MOTION TO STRIKE AND PRECLUDE PLAINTIFF’S WITNESSES AND EXHIBITS NOT PREVIOUSLY OR PROPERLY DISCLOSED

SHAFFER, United States Magistrate Judge.

THIS MATTER comes before the court on Defendants Darwin Poyfair, Michael Sabían and Freeborn & Peters’1 Motion to Strike and Preclude Plaintiffs Witnesses and Exhibits Not Previously or Properly Disclosed (hereinafter “Defendants’ Motion to Strike”), filed on April 5, 2004 (Document # 335), and Supplement thereto filed on April 9, 2004. Based upon Sender’s allegedly deficient Fed. R.Civ.P. 26(a)(1) disclosures, the Freeborn Defendants have moved to exclude witnesses and exhibits pursuant to Fed.R.Civ.P. 37(c)(1), arguing that Sender’s failure to disclose or properly supplement his initial disclosures lacked substantial justification and was not harmless under the particular circumstances of this case. Sender filed a Response to Freeborn Defendants’ Motion to Strike and Preclude Witnesses and Exhibits (hereinafter “Sender’s Response”) on April 26, 2004. The Freeborn Defendants filed their Reply in Support of Motion (hereinafter “Defendants’ Reply”) on May 11, 2004.

By Order of Reference, dated October 17, 2002, this matter was referred to the Magistrate Judge to, inter alia, “hear and determine pretrial matters, including discovery and other non-dispositive motions.” This court heard oral argument on the pending motion during hearings on May 18, and December 1, 2004. For the following reasons, the Freeborn Defendants’ motion is granted in part and denied in part.

FACTUAL BACKGROUND

This action was commenced on November 30, 2001 by Harvey Sender, Trustee of the Lifeblood Biomedical, Inc. Liquidation Trust and the Lifeblood Biomedical, Inc. Opt-in Trust. The original Complaint asserted 34 separate claims against 11 different defendants, including the Freeborn Defendants. An Amended Complaint was filed on December 7, 2001, and remained the operative pleading for purposes of Sender’s Rule 26(a)(1) disclosures.2 That pleading, totaling 76 pages, alleged facts and events that occurred between December 1996 and December 1999. Sender maintains that the Defen[648]*648dants participated or aided and abetted in a Ponzi scheme prior to the bankruptcy filing of Lifeblood Biomedical, Inc. The Amended Complaint generally alleged that Defendants Mann and Wells perpetrated a Ponzi scheme by issuing promissory notes through Lifeblood Biomedical, Inc. to approximately 200 individuals and entities who are now unsecured creditors of Lifeblood. See Amended Complaint, at ¶ 1. These unsecured creditors of Lifeblood are beneficiaries of the Liquidation Trust and many are also beneficiaries of the Opt-In Trust. It is alleged that Mann and Wells furthered their Ponzi scheme by falsely representing to investors and brokers that the promissory notes were being issued and backed by reputable business entities, that the promissory notes were bonded or insured, that the proceeds from the promissory notes would be used for legitimate business purposes, that interest payments on the promissory notes would be made and that the notes would be fully redeemed in nine months, upon maturity, and that Lifeblood Biomedical and related entities were viable companies actively engaged in legitimate business activities. See Amended Complaint, at ¶¶ 31-32. The Amended Complaint alleged that Mann and Wells were liable for fraud, breach of fiduciary duties, conspiracy, fraudulent transfers, and violations of the Racketeer Influenced and Corrupt Organizations Act (“RICO”), 18 U.S.C. §§ 1961 et seq., and the Colorado Organized Crime Control Act (“COCCA”), §§ 18-17-101 et seq.

The Amended Complaint further alleged that the Freeborn Defendants were liable for aiding and abetting the fraud and breach of fiduciary duties committed by Mann and Wells, aiding and abetting the RICO and COCCA violations committed by Mann and Wells, for breaching their own fiduciary duty to the Lifeblood entities, for legal malpractice, for receipt of fraudulent transfers, and for conspiring with other defendants. Sender specifically alleged in the Amended Complaint that Mann furthered his fraudulent schemes by retaining the Freeborn Defendants to represent Lifeblood Biomedical and a related entity. The Amended Complaint averred that the Freeborn Defendants were aware that Mann and Wells were “soliciting renewals of matured Promissory Notes that Lifeblood was unable to pay” and knew “that Mann and Wells had engaged in criminal conduct — a Ponzi scheme — in connection with the issuance and re-issuance of the Promissory Notes, and that Mann had been under investigation in connection with a promissory note scheme operated under the name of another company.” See Amended Complaint, at ¶ 68. Sender maintained that the Freeborn Defendants prepared and reviewed “scripts” that were intended “to assist Mann and Wells in responding to law enforcement inquiries and investor inquiries regarding such schemes and the Lifeblood Promissory Notes at a time when Mann and Wells sought to conceal Lifeblood’s inability to pay the Promissory Notes and their own diversion of funds.” See Amended Complaint, at ¶ 71.

On January 22, 2003, the parties filed a proposed Rule 16 Scheduling Order which contemplated that “each party shall be allowed up to 25 depositions.” This court accepted that numerical limitation without change. The court also accepted the discovery cut-off date of December 31, 2003, proposed by counsel for Sender and the Freeborn Defendants. The parties agreed to provide Rule 26(a)(1) disclosures by January 23, 2003.

Sender served his initial Rule 26(a)(1) disclosures on January 23, 2003. See Exhibit B attached to Defendants’ Motion to Strike. Those initial disclosures stated that “individuals likely to have discoverable information that Plaintiff may use to support his claims” included

[i]ndividuals who purchased Lifeblood promissory notes, listed on Exhibit A, attached. Such individuals have knowledge regarding the sale of promissory notes and the amounts owed to them pursuant to such notes.
Brokers and marketing agents through whom Messrs. Mann and Wells sold promissory notes, listed on Exhibit B, attached. Such individuals have knowledge regarding the sale of promissory notes and, in some instances, other schemes attempted or contemplated by Mann and Wells.

Referenced Exhibits A and B identified 196 investors and 126 brokers, respectively. A [649]*649cursory review of addresses included on Exhibits A and B reveals investors and brokers geographically dispersed in at least 17 different states ranging throughout the East Coast and as far west as California. Sender supplemented his initial disclosures on October 31, 2003, November 20, 2003, and February 24, 2004. See Exhibits C, D and E attached to Defendants’ Motion to Strike. None of these supplemental disclosures appear to reference investors or brokers, either generally or by specific name.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Davis v. Baldwin
S.D. Illinois, 2025
Morgan v. Logan County Commission
S.D. West Virginia, 2024
Morris v. Mingo Logan Coal LLC
S.D. West Virginia, 2024
LD v. United Behavioral Health
N.D. California, 2022

Cite This Page — Counsel Stack

Bluebook (online)
225 F.R.D. 645, 60 Fed. R. Serv. 3d 958, 2004 U.S. Dist. LEXIS 26684, 2004 WL 3127978, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sender-v-mann-cod-2004.